当前位置: 首页 > 期刊 > 《中国实用医药》 > 2008年第22期
编号:11641222
腹腔恶性肿瘤术后腹腔、淋巴、静脉联合化疗的临床研究及运用
http://www.100md.com 2008年8月5日 《中国实用医药》 2008年第22期
     【摘要】 目的研究腹腔胃肠道恶性肿瘤术后腹腔联合化疗较传统静脉全身化疗的优势。 方法比较5年来腹腔恶性肿瘤根治术后腹腔联合化疗和静脉化疗的生存率复发率的差异。 结果腹腔胃肠道恶性肿瘤术后腹腔联合化疗组患者1、2、3年生存率疗效明显高于静脉化疗组,复发率也具有显著性差异。 结论胃肠道恶性肿瘤根治术后腹腔联合化疗优于静脉全身化疗。

    【关键词】腹腔;恶性肿瘤;联合化疗

    Abdominal cavity after abdominal cancer,lymph,intravenous chemotherapy for joint research and clinical use

    HAO Yong-zhong,JIANG Zhuang-zhi,YIN Rong-nuan,et al.Guangdong Dongwuan Changping Hospital Surgical Department 2nd areas(General surgery)

    【Abstract】 ObjectiveTo the advontage of research abdominal gastrointestinal cancer after abdominal chemotherapy than traditional intravenous chemotherapy. MethodsOver the past five years compared abdominal gastrointestinal cancer after radical abdominal chemotherapy to intravenous chemotherapy and the survival rate of relapse rate differences. ResultsAfter abdominal gastrointestinal cancer in patients with abdominal chemotherapy group 1,2,3-year survival rate was significantly higher than the effect of intravenous chemotherapy,relapse rate also has significant differences. ConclusionThe cure effect of gastrointestinal cancer after radical abdominal chemotherapy is better than intravenous chemotherapy. ......

您现在查看是摘要页,全文长 5147 字符